Modified Bio-Bentall Operation With A Rapid Deployment Valve

This study reported favorable early outcomes in 11 intermediate- and high-risk patients who underwent a modified Bio-Bentall procedure with a rapid deployment valve between January 2018 and December 2022. 
 
The technique involved inserting an inverted 8 cm Valsalva graft into the left ventricular outflow tract using a single-layer continuous suture anastomosis. The graft was then exteriorized, and the coronary buttons were reimplanted. Three simple interrupted anchoring sutures were placed and the valve was deployed. 
 
The median patient age was 71 years, with the most common primary indication being annuloaortic ectasia with aortic insufficiency in six out of 11 patients. The median cardiopulmonary bypass and aortic cross-clamp times were 99 and 73 minutes, respectively. No early mortalities, reoperations, or paravalvular leaks were reported during follow-up. At one year, survival was 90.9 percent, and at three years, it was 54.5 percent. Permanent pacemaker implantation was required in three patients, with the authors attributing only one case to the rapid deployment technique.